Impulse News

Impulse Dynamics announces the first implantation of the Optimizer IVs device in a patient with a concomitant S-ICD in the United States

Orangeburg, New York – July 28, 2015 – Impulse Dynamics (USA), Inc. announced that Cardiac electrophysiologist, Andrew Kaplan, M.D., FACC, FHRS became the first physician in the United States to implant the Optimizer™ IVs investigational device as part of the FIX-HF-5C FDA IDE protocol in a heart failure patient with a previously implanted subcutaneous (under […]

Read more

Impulse Dynamics presented encouraging outcomes during EHRA EUROPACE Cardiostim, 21 – 24.06.2015

Stuttgart, Germany – 24th June 2015 – the unique advantages of the CCM therapy and its encouraging outcomes were presented during EHRA EUROPACE Cardiostim to professionals from around the globe. The CCM therapy has demonstrated its safety and efficacy through a number of randomized clinical trials. The results were displayed at two poster sessions and […]

Read more

Global growth for Impulse Dynamic’s Optimizer IVs device

Stuttgart, Germany – July 15, 2015 – Impulse Dynamics, part of The Hobart Group, announced today the first implantation of its Optimizer IVs device in Australia, showing global growth of its innovative technology.  The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). It has already been successfully launched in […]

Read more

CCM therapy was presented to an international audience during the 2014 Heart Failure congress in Sevilla, 23 – 26.05.2015

Stuttgart, Germany – 2 June, 2015 – following a series of presentations at DGK Mannheim and HRS Boston, clinical data on CCM and the Optimizer IVs system were presented to HFA in Sevilla from May 23 -26, 2015.  The international audience of professionals at the HFA was updated on the latest clinical evidence collected from […]

Read more

New Clinical Data on CCM Therapy to be Presented at HRS Boston, May 13-16 2015

Heart rhythm experts from around the world will gather in Boston to share groundbreaking research and learn of innovations in the field of cardiac electrophysiology. Stuttgart, Germany – 4 May, 2015 – New clinical data will be presented at the 36th Heart Rhythm Society Annual Scientific Sessions, in Boston from May 13 – 16, 2015. Five […]

Read more

Impulse Dynamics announced the first implantation of the Optimizer IVs device in China

Stuttgart, Germany – 9 January, 2015 – Impulse Dynamics announced today the first implantation of its Optimizer IVs device in China.  The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF).  The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses. The implantation […]

Read more

Impulse Dynamics announced the first enrollment in the IMPULSE-HF European Randomized Efficacy Study

October 2014 – Impulse Dynamics announced the first enrollment to the IMPULSE-HF European randomized controlled efficacy study in Europe at the Karolinska Institute, Stockholm, Sweden. “We are very happy to enroll the first patient in the IMPULSE-HF study and we look forward to gain experience with the CCM therapy in Sweden” said Prof. Cecilia Linde […]

Read more

Impulse Dynamics announced the first implantation of the Optimizer IVs device in the Czech Republic

Impulse Dynamics announced the first implantation of the Optimizer IVs device in the Czech Republic earlier this summer. The implantation took place at the Na Homolce Hospital in Prague (Czech Republic) by Prof. Petr Neuzil, M.D., Head of cardiology. The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). […]

Read more

Impulse Dynamics Announces Enrollment of the First Subject in the FIX-HF-5C Confirmatory Study of the Optimizer™ IVs System in NYHA Class III/IV Heart Failure Patients

Orangeburg, NY – August 4, 2014 Impulse Dynamics (USA), Inc. announced today that the first US implant of the Optimizer™ IVs System in the FIX-HF-5C Confirmatory Study was performed by Stanislav Weiner, M.D. at Mother Frances Hospital in Tyler, Texas. The study is designed to evaluate the safety and efficacy of the Optimizer™ IVs System […]

Read more